Scientific Advisory Board

METAvivor's research program is advised by a team of preeminent scientists and oncologists specializing in metastatic cancer research and treatment. In addition to providing expertise regarding the research that METAvivor funds, our Research Advisory Board also supports the METAvivor patient community with up-to-date information about relevant news and progress regarding research and treatment for metastatic breast cancer.

Dr. Danny R Welch

Founding Director of the University of Kansas Medical Center’s (KUMC) Department of Cancer Biology

Director of the NFCR’s (National Foundation for Cancer Research) Metastasis Research Center

Professor and Chair, Adjunct faculty of Department of Molecular & Integrative Physiology (KUMC)

Dr. Young J. Lee, MD

Chief of Oncology Harbor Hospital Baltimore, Maryland

Dr. Stuart. S. Martin, PhD.

Associate Professor at the Greenebaum Cancer Center, University of Maryland, Baltimore